DVAX
Price
$10.22
Change
-$0.03 (-0.29%)
Updated
Aug 28, 03:56 PM (EDT)
Capitalization
1.22B
63 days until earnings call
SHOT
Price
$0.40
Change
-$0.02 (-4.76%)
Updated
Aug 28, 04:19 PM (EDT)
Capitalization
64.7M
6 days until earnings call
Interact to see
Advertisement

DVAX vs SHOT

Header iconDVAX vs SHOT Comparison
Open Charts DVAX vs SHOTBanner chart's image
Dynavax Technologies
Price$10.22
Change-$0.03 (-0.29%)
Volume$1.02K
Capitalization1.22B
Safety Shot
Price$0.40
Change-$0.02 (-4.76%)
Volume$1.5K
Capitalization64.7M
DVAX vs SHOT Comparison Chart in %
Loading...
DVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DVAX vs. SHOT commentary
Aug 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DVAX is a Buy and SHOT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 28, 2025
Stock price -- (DVAX: $10.26 vs. SHOT: $0.42)
Brand notoriety: DVAX and SHOT are both not notable
DVAX represents the Pharmaceuticals: Generic, while SHOT is part of the Beverages: Non-Alcoholic industry
Current volume relative to the 65-day Moving Average: DVAX: 98% vs. SHOT: 33%
Market capitalization -- DVAX: $1.22B vs. SHOT: $64.7M
DVAX [@Pharmaceuticals: Generic] is valued at $1.22B. SHOT’s [@Beverages: Non-Alcoholic] market capitalization is $64.7M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.86B to $0. The market cap for tickers in the [@Beverages: Non-Alcoholic] industry ranges from $296.22B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.8B. The average market capitalization across the [@Beverages: Non-Alcoholic] industry is $20.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DVAX’s FA Score shows that 0 FA rating(s) are green whileSHOT’s FA Score has 0 green FA rating(s).

  • DVAX’s FA Score: 0 green, 5 red.
  • SHOT’s FA Score: 0 green, 5 red.
According to our system of comparison, both DVAX and SHOT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DVAX’s TA Score shows that 4 TA indicator(s) are bullish while SHOT’s TA Score has 4 bullish TA indicator(s).

  • DVAX’s TA Score: 4 bullish, 6 bearish.
  • SHOT’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, DVAX is a better buy in the short-term than SHOT.

Price Growth

DVAX (@Pharmaceuticals: Generic) experienced а -1.54% price change this week, while SHOT (@Beverages: Non-Alcoholic) price change was -14.37% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.10%. For the same industry, the average monthly price growth was +11.51%, and the average quarterly price growth was +89.56%.

The average weekly price growth across all stocks in the @Beverages: Non-Alcoholic industry was -0.79%. For the same industry, the average monthly price growth was -0.45%, and the average quarterly price growth was +2.97%.

Reported Earning Dates

DVAX is expected to report earnings on Oct 30, 2025.

SHOT is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

@Beverages: Non-Alcoholic (-0.79% weekly)

Non-alcoholic drinks include traces of alcohol or low alcohol content or without alcohol or alcohol removed. Functional Beverages, Carbonated Soft Drinks (CSDs), Sports Drinks, Fruit Beverages, and Bottled Water are some common types of non-alcoholic beverages. The largest segment in this market is soft drinks (think Pepsi and Coke). Many established companies in this space have also been stepping up production of low to zero-calorie varieties in recent years, to cater to a rising number of health-conscious consumers. Coca-Cola Company, Pepsico Inc, Keurig Dr Pepper Inc. and Monster Beverage Corporation are some major non-alcoholic beverage makers.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DVAX($1.22B) has a higher market cap than SHOT($64.7M). DVAX YTD gains are higher at: -19.655 vs. SHOT (-42.153). SHOT has higher annual earnings (EBITDA): -15.73M vs. DVAX (-34.26M). DVAX has more cash in the bank: 614M vs. SHOT (18.7M). SHOT has less debt than DVAX: SHOT (10.5M) vs DVAX (285M). DVAX has higher revenues than SHOT: DVAX (316M) vs SHOT (-91.96K).
DVAXSHOTDVAX / SHOT
Capitalization1.22B64.7M1,892%
EBITDA-34.26M-15.73M218%
Gain YTD-19.655-42.15347%
P/E Ratio54.60N/A-
Revenue316M-91.96K-343,643%
Total Cash614M18.7M3,283%
Total Debt285M10.5M2,714%
FUNDAMENTALS RATINGS
DVAX: Fundamental Ratings
DVAX
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
85
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DVAXSHOT
RSI
ODDS (%)
Bearish Trend 4 days ago
67%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 16 days ago
75%
Bullish Trend 28 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
DVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMXEF1.650.03
+1.73%
Amex Exploration Inc.
BPHLF1.62N/A
N/A
Bank of the Philippine Islands
GMGZ0.23N/A
N/A
Genuine Marketing Group Inc.
SLMUF11.00N/A
N/A
Slam Corp.
ANZLY1.65N/A
N/A
Air New Zealand Ltd.

DVAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, DVAX has been loosely correlated with ACET. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if DVAX jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DVAX
1D Price
Change %
DVAX100%
-1.72%
ACET - DVAX
39%
Loosely correlated
+2.57%
SNDL - DVAX
35%
Loosely correlated
+2.43%
AMRX - DVAX
33%
Poorly correlated
-0.21%
ESPR - DVAX
32%
Poorly correlated
-0.46%
BCRX - DVAX
32%
Poorly correlated
-0.70%
More

SHOT and

Correlation & Price change

A.I.dvisor tells us that SHOT and PBH have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHOT and PBH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHOT
1D Price
Change %
SHOT100%
-6.74%
PBH - SHOT
23%
Poorly correlated
+0.83%
CPIX - SHOT
21%
Poorly correlated
N/A
SNDL - SHOT
21%
Poorly correlated
+2.43%
DVAX - SHOT
21%
Poorly correlated
-1.72%
TLRY - SHOT
21%
Poorly correlated
-5.52%
More